Guizhou Xinbang Pharmaceutical Co Ltd (002390) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.034x

Based on the latest financial reports, Guizhou Xinbang Pharmaceutical Co Ltd (002390) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥234.19 Million ≈ $34.27 Million USD) by net assets (CN¥6.97 Billion ≈ $1.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Guizhou Xinbang Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.

Guizhou Xinbang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Guizhou Xinbang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002390 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Guizhou Xinbang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Xinbang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
CoAsia Microelectronics
TWO:8096
-0.504x
Hunan Jiudian Pharmaceutical Co Ltd
SHE:300705
0.068x
Forward Industries Inc
NASDAQ:FORD
-0.002x
SeAH Bestee
KO:001430
0.007x
Shenzhen Fuanna Bedding and Furnishing Co Ltd
SHE:002327
0.030x
Kvutzat Acro Ltd.
TA:ACRO
-0.030x
China Railway Signal & Communication Corporation Limited
F:RS3
0.008x
Salfacorp
SN:SALFACORP
0.128x

Annual Cash Flow Conversion Efficiency for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Guizhou Xinbang Pharmaceutical Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Guizhou Xinbang Pharmaceutical Co Ltd market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥7.02 Billion
≈ $1.03 Billion
CN¥634.97 Million
≈ $92.92 Million
0.090x -18.29%
2023-12-31 CN¥7.14 Billion
≈ $1.05 Billion
CN¥790.62 Million
≈ $115.69 Million
0.111x +32.38%
2022-12-31 CN¥7.07 Billion
≈ $1.03 Billion
CN¥590.80 Million
≈ $86.45 Million
0.084x +24.68%
2021-12-31 CN¥6.83 Billion
≈ $999.22 Million
CN¥457.97 Million
≈ $67.02 Million
0.067x -53.29%
2020-12-31 CN¥5.17 Billion
≈ $756.31 Million
CN¥742.11 Million
≈ $108.59 Million
0.144x -18.22%
2019-12-31 CN¥5.05 Billion
≈ $738.73 Million
CN¥886.33 Million
≈ $129.70 Million
0.176x +515.18%
2018-12-31 CN¥5.17 Billion
≈ $756.32 Million
CN¥-218.56 Million
≈ $-31.98 Million
-0.042x -241.67%
2017-12-31 CN¥6.76 Billion
≈ $989.00 Million
CN¥201.74 Million
≈ $29.52 Million
0.030x +197.48%
2016-12-31 CN¥6.49 Billion
≈ $948.96 Million
CN¥-198.59 Million
≈ $-29.06 Million
-0.031x -137.59%
2015-12-31 CN¥2.67 Billion
≈ $390.56 Million
CN¥217.40 Million
≈ $31.81 Million
0.081x +200.81%
2014-12-31 CN¥2.46 Billion
≈ $359.67 Million
CN¥-198.60 Million
≈ $-29.06 Million
-0.081x -292.27%
2013-12-31 CN¥1.04 Billion
≈ $151.59 Million
CN¥-21.34 Million
≈ $-3.12 Million
-0.021x +42.23%
2012-12-31 CN¥1.02 Billion
≈ $149.64 Million
CN¥-36.46 Million
≈ $-5.34 Million
-0.036x +12.39%
2011-12-31 CN¥979.53 Million
≈ $143.34 Million
CN¥-39.87 Million
≈ $-5.83 Million
-0.041x -1661.76%
2010-12-31 CN¥959.70 Million
≈ $140.43 Million
CN¥2.50 Million
≈ $365.97K
0.003x -98.42%
2009-12-31 CN¥252.83 Million
≈ $37.00 Million
CN¥41.75 Million
≈ $6.11 Million
0.165x +37.96%
2008-12-31 CN¥207.69 Million
≈ $30.39 Million
CN¥24.86 Million
≈ $3.64 Million
0.120x -35.86%
2007-12-31 CN¥174.08 Million
≈ $25.47 Million
CN¥32.49 Million
≈ $4.75 Million
0.187x +266.24%
2006-12-31 CN¥144.17 Million
≈ $21.10 Million
CN¥7.35 Million
≈ $1.07 Million
0.051x --

About Guizhou Xinbang Pharmaceutical Co Ltd

SHE:002390 China Drug Manufacturers - Specialty & Generic
Market Cap
$787.92 Million
CN¥5.38 Billion CNY
Market Cap Rank
#10088 Global
#2689 in China
Share Price
CN¥2.77
Change (1 day)
+1.09%
52-Week Range
CN¥2.60 - CN¥4.15
All Time High
CN¥14.40
About

Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological m… Read more